|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2041 USD | -1.89% |
|
-1.99% | -95.17% |
| Apr. 15 | Abpro Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Apr. 14 | Abpro Holdings, Inc. Auditor Raises 'Going Concern' Doubt | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Biological Products | |||||||
Biotechnology (Startups) | 480K | 2.03M | 122K | 183K | - | ||
Total Assets | 7.89M | 11.85M | 3.36M | 4.66M | 1.06M | ||
Interest Expense | -42K | -248K | -23K | -387K | -1.13M | ||
Income Tax Expense | - | 330K | - | - | - | ||
CAPEX | -12K | - | -48K | - | - | ||
EBT | -14.74M | -16.88M | -11.71M | -7.23M | -2.89M | ||
D&A | 523K | 856K | 792K | 622K | 439K | ||
Operating Income | -14.98M | -16.68M | -11.75M | -9.92M | -8.45M | ||
Net Income | -14.74M | -17.22M | -11.71M | -7.23M | -2.89M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
United States | 480K | 2.03M | 122K | 183K | - | ||
Total Assets | 7.89M | 11.85M | 3.36M | 4.66M | 1.06M | ||
Interest Expense | -42K | -248K | -23K | -387K | -1.13M | ||
Income Tax Expense | - | 330K | - | - | - | ||
D&A | 523K | 856K | 792K | 622K | 439K | ||
CAPEX | -12K | - | -48K | - | - | ||
Net Income | -14.74M | -17.22M | -11.71M | -7.23M | -2.89M | ||
EBT | -14.74M | -16.88M | -11.71M | -7.23M | -2.89M | ||
Operating Income | -14.98M | -16.68M | -11.75M | -9.92M | -8.45M |
- Stock Market
- Equities
- ABPO Stock
- Financials Abpro Holdings, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
